Atypical femoral fractures due to the use of bisphosphonates. Experience of two institutions
bisphosphonates are used for the management of postmenopausal osteoporosis with high risk of fracture, glucocorticoid-induced osteoporosis, Paget's disease and hypercalcemia; as well as an adjuvant for the management of hyperparathyroidism. Bisphosphonates have been associated with previously u...
Gespeichert in:
| Veröffentlicht in: | Acta ortopédica mexicana 2023-09, Vol.37 (5), p.270-275 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | spa |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!